Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding

BACKGROUND: Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients and has also been used for a diverse range of off-label indications in the context of massive uncontrolled blood loss; however, no convincing evidence exists regarding th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Zhi-gang, Chu, Xin, Chen, Wen, Hu, Jun-hua, Gong, Ji-wu, Liu, Da-dong, He, Qing, Feng, Zhe, Xiao, Shi-rou, Liu, Ya-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686627/
https://www.ncbi.nlm.nih.gov/pubmed/33281510
http://dx.doi.org/10.1177/1559325820969569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686627/
https://www.ncbi.nlm.nih.gov/pubmed/33281510
http://dx.doi.org/10.1177/1559325820969569

Ejemplares similares